Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.35 |
| ▸ | SQLE | Q14534 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1305370 | 1.00 | ALOX15 (0.38) | ALOX15KMT2ACYP3A4MEN1MAPK1 | |
| SCHEMBL1305371 | 1.00 | ALOX15 (0.38) | ALOX15KMT2ACYP3A4MEN1MAPK1 | |
| SCHEMBL28249469 | 0.91 | KMT2A (0.34) | ALOX15KMT2ACYP3A4MEN1MAPK1 | |
| SCHEMBL19330819 | 0.84 | — | — | |
| SCHEMBL28328825 | 0.84 | MEN1 (0.30) | ALOX15KMT2ACYP3A4MEN1MAPK1 | |
| SCHEMBL4119500 | 0.83 | — | — | |
| SCHEMBL18462872 | 0.77 | KMT2A (0.61) | ALOX15KMT2ACYP3A4MEN1MAPT | |
| SCHEMBL6200876 | 0.74 | — | — | |
| SCHEMBL6200882 | 0.74 | — | — | |
| SCHEMBL6580256 | 0.73 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | GIVAUDAN SA (CH) | 2026-05-07 | — | — | US | claimed |
| EP-4735561-A1 | MODIFIED BLACK SOLDIER FLY OIL EXTRACT AND USES THEREOF | NeoManna Ltd (IL) | 2026-05-06 | — | — | EP | claimed |
| EP-4709355-A1 | CANNABINOID-BASED FORMULATION | MRX Medical Limited (GB) | 2026-03-18 | — | — | EP | claimed |
| US-20260068922-A1 | LIQUID COMPOSITION FOR AN ELECTRONIC VAPOR DEVICE | CRONOS GROUP INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705494-A1 | METHODS FOR THE PRODUCTION AND RECOVERY OF VOLATILE MOLECULES | Amyris, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20250304851-A1 | METHODS AND COMPOSITIONS USED IN CONTROLLING FORMATION SAND PRODUCTION, PROPPANT FLOWBACK, AND FINES MIGRATION | HALLIBURTON ENERGY SERVICES, INC | 2025-10-02 | — | — | US | claimed |
| EP-4604742-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | Givaudan SA (CH) | 2025-08-27 | — | — | EP | claimed |
| US-20250243302-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-07-31 | — | — | US | claimed |
| WO-2025129179-A1 | FREE RADICAL ETHYLENE/TERPENE COPOLYMERS | BRASKEM S.A. (BR) | 2025-06-19 | — | — | WO | claimed |
| CN-120082448-A | Saccharomyces cerevisiae engineering strain for producing bisabolene and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-112877228-B | Saccharomyces cerevisiae engineering bacterium for high yield of bisabolene and application thereof | 浙江工业大学 | 2022-06-21 | — | — | CN | claimed |
| US-20220183992-A1 | Edible Film Comprising Adjacent Conjoined Strips | TERPENE THERAPEUTICS INC (CA) | 2022-06-16 | — | — | US | claimed |
| CN-114600916-A | Application of polygonum hydropiper essential oil in inhibiting Neoestaltolopsis rosae | 湖北工程学院 | 2022-06-10 | — | — | CN | claimed |
| CN-114555816-A | Improved process for the production, recovery and secretion of hydrophobic compounds in fermentation | 佰欧菲洛公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114438109-A | Osmanthus gene OfTPS13.2 and application thereof | 华中农业大学 | 2022-05-06 | — | — | CN | claimed |
| WO-2022079128-A2 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | GIVAUDAN SA (CH) | 2022-04-21 | — | — | WO | claimed |
| WO-2022081174-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEVELOPMENT, LLC (US) | 2022-04-21 | — | — | WO | claimed |
| EP-3981869-A1 | ARGININE AS SOLE NITROGEN SOURCE FOR C1-FIXING MICROORGANISM | LanzaTech NZ, Inc. (US) | 2022-04-13 | — | — | EP | claimed |
| WO-2022065643-A1 | RECOMBINANT MICROORGANISM COMPRISING POLYNUCLEOTIDE ENCODING TARGET PRODUCT BINDING PROTEIN FUSED TO SECRETION SIGNAL SEQUENCE, COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME | 한국화학연구원 | 2022-03-31 | — | — | WO | claimed |
| WO-2022066700-A1 | INFRARED SPECTROSCOPIC METHODS FOR EVALUATING COMPOSITIONS | CENTRAL COAST AGRICULTURE, INC. (US) | 2022-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | RBP4, RBP1, PROC | ALOX15 819/4885KMT2A 1512/4885CYP3A4 4649/4885 |
| US-20260068922-A1 | LIQUID COMPOSITION FOR AN ELECTRONIC VAPOR DEVICE | CNR2, CNR1, TRPV1 | ALOX15 249/4885KMT2A 2722/4885CYP3A4 96/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.